Systemic mastocytosis with associated hematologic neoplasm (SM-AHN) presents unique diagnostic and treatment challenges. In this Medscape-certified activity, experts discuss the complex patient journey, from delayed diagnosis to individualized…
Avapritinib, branded as Ayvakit, became the first FDA-approved treatment for indolent systemic mastocytosis (ISM) in 2023, marking a major advancement for patients. ISM, driven by the KIT D816V…
Yogitha Namasani, MD discusses two recent leukemia cases. The first involved a patient with acute leukemia diagnosed through peripheral smear, flow cytometry, and bone marrow studies, which confirmed…
Allison Betof Warner, MD from Stanford Healthcare discusses recent advancements in treating advanced melanoma with a newly FDA-approved cell-based therapy. This innovative treatment is designed for patients who…
Rafael Fonseca, MD, discusses the evolving landscape of multiple myeloma treatment. While traditionally deemed incurable, Dr. Fonseca highlights a growing fraction of patients achieving sustained, durable, and potentially…
Learn about Interventional Pulmonology and Thoracic Oncology with Scott Oh, MD, an Interventional Pulmonologist at UCLA and a Professor of Medicine at the David Geffen School of Medicine.…
Explore the atypical signs and symptoms of lung cancer, including the rare paraneoplastic syndromes caused by the disease. Learn about small cell carcinoma’s manifestations like Lambert-Eaton myasthenic syndrome,…
Multiple Myeloma is a cancer that affects plasma cells in bone marrow. Abnormal plasma cells produce harmful proteins, leading to anemia, bone pain, frequent infections, and kidney failure.…
A groundbreaking trial in the UK is testing the world’s first “personalized” mRNA vaccine against the deadliest form of skin cancer, melanoma. This innovative vaccine is tailored to…
This is a comprehensive overview of Chronic Myelogenous Leukemia (CML), a rare type of cancer affecting bone marrow and blood cell development. Arpan Parichha, MD discusses the disease’s…
Michael Hofman, FRACP, MBBS, explores the evolving landscape of imaging techniques in the diagnosis and treatment of renal cell carcinoma, particularly focusing on PET-CT scans. Historically underutilized in…
Learn about the specifics of treating non-small cell lung cancer (NSCLC) when a KRAS mutation is present. The KRAS gene, often mutated in several cancers including NSCLC, signals…
